This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Generon (Shanghai) Corporation Ltd.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Hanyang Chen - Innovator in Multispecific Fab Fusion Proteins
Introduction
Hanyang Chen is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of multispecific Fab fusion proteins. His innovative work has the potential to impact cancer treatment and pharmaceutical compositions.
Latest Patents
Hanyang Chen holds a patent for "Multispecific Fab fusion proteins and use thereof." This invention provides multispecific Fab fusion proteins (MSFP) that specifically bind to CD3 and EpCAM. The patent outlines the uses of these MSFPs for preparing pharmaceutical compositions, methods of treating cancer, and kits that include the MSFPs. Additionally, it covers anti-EpCAM antibodies or antigen-binding fragments thereof.
Career Highlights
Hanyang Chen is associated with Generon (Shanghai) Corporation Ltd., where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and excellence in the biotechnology sector.
Collaborations
Hanyang collaborates with notable colleagues, including Yumin Cui and Zhihua Huang. Their combined expertise enhances the research and development initiatives at Generon.
Conclusion
Hanyang Chen's contributions to the field of biotechnology, particularly through his patent on multispecific Fab fusion proteins, demonstrate his innovative spirit and dedication to improving cancer treatment options. His work continues to inspire advancements in pharmaceutical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile